原位与侵袭性皮肤黑色素瘤的胚系遗传学:全基因组关联研究荟萃分析
该研究通过三项全基因组关联分析荟萃分析,比较原位黑色素瘤与侵袭性黑色素瘤的胚系遗传差异。研究发现两者共享大部分遗传结构,遗传相关性高(r=0.96),但部分位点效应不同,且基于侵袭性vs原位的多基因风险评分与侵袭性黑色素瘤风险相关(每1-SD OR=1.43)。
要点
- 原位与侵袭性黑色素瘤共享高度遗传相关性(r=0.96)。
- IRF4、KLF4、HULC near位点对原位黑色素瘤效应更大,MC1R对侵袭性效应更大。
- 基于侵袭性vs原位的PRS可区分侵袭性风险(每1-SD OR=1.43)。
核心结论
- 原位与侵袭性黑色素瘤共享大部分遗传结构,但胚系遗传可能影响个体发展为原位或侵袭性黑色素瘤。
- 基于侵袭性vs原位比较的PRS可能有助于人群侵袭性黑色素瘤风险分层。
研究设计与样本
- 研究采用三项全基因组关联研究荟萃分析:原位黑色素瘤vs对照、侵袭性黑色素瘤vs对照、原位vs侵袭性(病例-病例)。
- 数据来自UK Biobank、FinnGen队列、QSkin Sun and Health Study和Q-MEGA四个基于人群的遗传队列。
- 黑色素瘤状态依据癌症登记数据的ICD编码确定,数据收集于1987至2022年,分析于2022年9月至2023年6月。
主要发现
- 共识别6个与原位黑色素瘤全基因组显著相关的位点和18个与侵袭性黑色素瘤相关的位点。
- 两分类间遗传相关性高:遗传r=0.96(95% CI, 0.76-1.15)。
- IRF4、KLF4和HULC附近位点对原位黑色素瘤效应显著大于侵袭性,MC1R对侵袭性黑色素瘤效应显著大于原位。
- 遗传力估计一致:原位黑色素瘤遗传力6.7%(95% CI, 4.1-9.3),侵袭性黑色素瘤遗传力4.9%(95% CI, 2.8-7.2)。
- 基于侵袭性vs原位遗传风险的PRS在侵袭性黑色素瘤参与者中平均显著更高(每1-SD增加OR=1.43;95% CI, 1.16-1.77)。
临床怎么用
- PRS可能辅助识别侵袭性黑色素瘤高风险人群,用于未来筛查项目设计。
- 应用PRS分层可能避免加重当前黑色素瘤过度诊断负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is unknown whether germline genetic factors influence in situ melanoma risk differently than invasive melanoma risk. OBJECTIVE: To determine whether differences in risk of in situ melanoma and invasive melanoma are heritable. DESIGN, SETTING, AND PARTICIPANTS: Three genome-wide association study meta-analyses were conducted of in situ melanoma vs controls, invasive melanoma vs controls, and in situ vs invasive melanoma (case-case) using 4 population-based genetic cohorts: the UK Biobank, the FinnGen cohort, the QSkin Sun and Health Study, and the Queensland Study of Melanoma: Environmental and Genetic Associations (Q-MEGA). Melanoma status was determined using International Statistical Classification of Diseases and Related Health Problems codes from cancer registry data. Data were collected from 1987 to 2022, and data were analyzed from September 2022 to June 2023. EXPOSURE: In situ and invasive cutaneous melanoma. MAIN OUTCOMES AND MEASURES: To test whether in situ and invasive melanoma have independent heritable components, genetic effect estimates were calculated for single-nucleotide variants (SNV; formerly single-nucleotide polymorphisms) throughout the genome for each melanoma. Then, SNV-based heritability was estimated, the genetic correlation between melanoma subtypes was assessed, and polygenic risk scores (PRS) were generated for in situ vs invasive status in Q-MEGA participants. RESULTS: A total of 6 genome-wide significant loci associated with in situ melanoma and 18 loci with invasive melanoma were identified. A strong genetic correlation (genetic r = 0.96; 95% CI, 0.76-1.15) was observed between the 2 classifications. Notably, loci near IRF4, KLF4, and HULC had significantly larger effects for in situ melanoma compared with invasive melanoma, while MC1R had a significantly larger effect on invasive melanoma compared with in situ melanoma. Heritability estimates were consistent for both, with in situ melanoma heritability of 6.7% (95% CI, 4.1-9.3) and invasive melanoma heritability of 4.9% (95% CI, 2.8-7.2). Finally, a PRS, derived from comparing invasive melanoma with in situ melanoma genetic risk, was on average significantly higher in participants with invasive melanoma (odds ratio per 1-SD increase in PRS, 1.43; 95% CI, 1.16-1.77). CONCLUSIONS AND RELEVANCE: There is much shared genetic architecture between in situ melanoma and invasive melanoma. Despite indistinguishable heritability estimates between the melanoma classifications, PRS suggest germline genetics may influence whether a person gets in situ melanoma or invasive melanoma. PRS could potentially help stratify populations based on invasive melanoma risk, informing future screening programs without exacerbating the current burden of melanoma overdiagnosis.
引用
- Ingold N, Seviiri M, Ong JS, et al. Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma: A Genome-Wide Association Study Meta-Analysis. JAMA Dermatol. 2024. PMID: 39141363. doi:10.1001/jamadermatol.2024.2601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。